Active16786044Private limited companyLondon

GENETRA LIMITED

Significant control: Nabeel Amer Sheikh (25–50%), Asma Naaz (25–50%)

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Genetra Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Genetra Limited sell?

Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

GENETRA LIMITED is an active private limited company (company number 16786044) incorporated on 15 October 2025, registered in London. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 31 March 2026, showing net assets of −£12k and cash of £4,909, with 0 employees on average.

Peer position · net assets

By net assets it sits in the bottom quarter of 76 comparable companies in London (median £100, upper quartile £88k).

Ownership and control

2 active

NA
Mr Nabeel Amer Sheikh
Individual · since 15 October 2025
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
25–50%
AN
Miss Asma Naaz
Individual · since 12 May 2026
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 15 October 20251 yr ago
Next accounts due: 31 December 2027in 432 days
Confirmation statement due: 29 October 2026in 4 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 21200: Manufacture of pharmaceutical preparations
SIC 46460: Wholesale of pharmaceutical goods
SIC 47910: Retail sale via mail order houses or via Internet
SIC 72110: Research and experimental development on biotechnology
Accounts type: Total Exemption Full
Size band: MicroCompanies Act thresholds

Financials

1 period on record · latest ending 31 March 2026

Net assets

−£12k

1 period on record

Cash at bank

£4,909

1 period on record

Turnover

Not reported

Employees

1 period on record

Filed accounts by period, newest first
Period end	Net assets	Cash	Debtors	Creditors <1y	Turnover	Profit	Employees
31 March 2026	−£12k	£4,909	£2,320	£20k	—	—	0

Current ratio0.37Current assets ÷ creditors within one year

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

Filing and accounts signals

Facts from the register · no rating

Net assets below zeroNet assets £-12,353 at 31 March 2026
Current assets below creditors within one yearCurrent ratio 0.37
Incorporated less than two years agoIncorporated 15 October 2025; no accounts due yet

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

31 Dec 2027Next accounts duein 432 days
29 Oct 2026Confirmation statement duein 4 days
31 Mar 2026Accounts period endNet liabilities £12k · small accounts
15 Oct 2025Incorporated

Similar companies in London

Same activity (manufacture of pharmaceutical preparations), closest in incorporation date

All companies incorporated on 15 October 2025 · in Oct 2025.

Reminders for GENETRA LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.